Information about AgomAb Therapeutics
My details
*
*
*

AgomAb Therapeutics (SA)

Company information

Status
Active

Enterprise number

BE0674.527.310

VAT liability
Yes
Established
13-04-2017
Last balance sheet year
2024
Company size
Big 40,9 FTE
Commercial name
Agomab
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from AgomAb Therapeutics

2024 2023 2022 2021
Profit/Loss -11,716,884 -39 % -8,440,501 10 % -9,396,576 -45 % -6,484,466
Equity 253,687,197 38 % 183,349,854 89 % 96,919,958 43 % 67,933,769
Gross margin 3,962,010 168 % 1,477,010 49 % 993,210 119 % -5,325,621
Employees 40.9 19.4 10.1 3.8

Publications from AgomAb Therapeutics

Date Publication
17-06-2025 Resignations - Appointments (NL)
19-11-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital - Shares - Resignations - Appointments (NL)
18-07-2024 Miscellaneous - Resignations - Appointments (NL)
17-07-2024 Resignations - Appointments (NL)
09-04-2024 Registered Office (NL)

Frequently asked questions

What is the VAT number of AgomAb Therapeutics?
The VAT number of AgomAb Therapeutics is BE 0674.527.310.
Wat is the PEPPOL ID of AgomAb Therapeutics?
There is no information available about the PEPPOL ID of AgomAb Therapeutics or the company is not yet registered on the PEPPOL network.
When was AgomAb Therapeutics founded?
AgomAb Therapeutics was founded on 13-04-2017.
What is the address of AgomAb Therapeutics?
The current registered office of AgomAb Therapeutics is located at Posthoflei 1/6, 2600 Antwerpen.
When was the last time AgomAb Therapeutics filed their annual financial statements?
The most recent financial statements of AgomAb Therapeutics were filed on 09-06-2025.
How many employees does AgomAb Therapeutics have?
There are 40,9 FTEs working at AgomAb Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of AgomAb Therapeutics?
At the time of its most recent financial statements, AgomAb Therapeutics did not publish any turnover figures. AgomAb Therapeutics reported a gross margin of €3,962,009.50.